Nexavar

Latest stories

19d
The Hindu
Two Indian generics makers end battle to copy drugsa compulsory license for a medicine in 2012, allowing Natco Pharma to sell a co
Two Indian generics makers end battle to copy drugs
The Hindu / Posted 19 days ago
a compulsory license for a medicine in 2012, allowing Natco Pharma to sell a copy of German drugmaker Bayer's cancer drug Nexavar at a tenth of the original price. The move was criticized by large multinationals. But BDR's application to copy... Read more
3 related stories
19d
Business Standard India
Two Indian generics makers end battle to copy drugs amid patent debatea compulsory license for a medicine in 2012, allowing Natco Pharma to sell a c
Two Indian generics makers end battle to copy drugs amid patent debate
Business Standard India / Posted 19 days ago
a compulsory license for a medicine in 2012, allowing Natco Pharma to sell a copy of German drugmaker Bayer's cancer drug Nexavar at a tenth of the original price. The move was criticised by large multinationals. But BDR's application to copy... Read more
3 related stories
19d
The Economic Times
Two generics makers end battle to copy drugs amid patent debatea compulsory license for a medicine in 2012, allowing Natco Pharma to sell a co
Two generics makers end battle to copy drugs amid patent debate
The Economic Times / Posted 19 days ago
a compulsory license for a medicine in 2012, allowing Natco Pharma to sell a copy of German drugmaker Bayer's cancer drug Nexavar at a tenth of the original price. The move was criticised by large multinationals. But BDR's application to copy... Read more
3 related stories
19d
Channel NewsAsia
Two Indian generics makers end battle to copy drugs amid patent debatea compulsory license for a medicine in 2012, allowing Natco Pharma to sell a co
Two Indian generics makers end battle to copy drugs amid patent debate
Channel NewsAsia / Posted 19 days ago
a compulsory license for a medicine in 2012, allowing Natco Pharma to sell a copy of German drugmaker Bayer's cancer drug Nexavar at a tenth of the original price. The move was criticized by large multinationals. But BDR's application to copy... Read more
3 related stories
29d
TribLIVE
Bayer increases marketing, research operations to expand foothold in U.S.infections; Yasmin birth control pills; the Mirena intrauterine device; erectil
Bayer increases marketing, research operations to expand foothold in U.S.
TribLIVE / Posted 29 days ago
infections; Yasmin birth control pills; the Mirena intrauterine device; erectile dysfunction pill Levitra; cancer drugs Nexavar and Stivarga; Betaseron for multiple sclerosis; hemophilia treatments Kogenate and Kovaltry; and Xarelto, the top... Read more
8 related stories
30d
Daily Herald
A look at Bayer AGinfections; Yasmin birth control pills; the Mirena intrauterine device; erectil
A look at Bayer AG
Daily Herald / Posted 30 days ago
infections; Yasmin birth control pills; the Mirena intrauterine device; erectile dysfunction pill Levitra; cancer drugs Nexavar and Stivarga, Betaseron for multiple sclerosis; hemophilia treatments Kogenate and Kovaltry; and Xarelto, the top... Read more
8 related stories
30d
The Tampa Tribune
A look at Bayer AGinfections; Yasmin birth control pills; the Mirena intrauterine device; erectil
A look at Bayer AG
The Tampa Tribune / Posted 30 days ago
infections; Yasmin birth control pills; the Mirena intrauterine device; erectile dysfunction pill Levitra; cancer drugs Nexavar and Stivarga, Betaseron for multiple sclerosis; hemophilia treatments Kogenate and Kovaltry; and Xarelto, the top... Read more
8 related stories

People in this news